<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AimsTo describe the outcome of pregnancy in patients with structural or <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischaemic heart disease</z:e>.Methods and resultsIn 2007, the European Registry on Pregnancy and <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">Heart disease</z:e> was initiated by the European Society of Cardiology </plain></SENT>
<SENT sid="1" pm="."><plain>Consecutive patients with <z:hpo ids='HP_0001654'>valvular heart disease</z:hpo>, <z:hpo ids='HP_0002564'>congenital heart disease</z:hpo>, <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischaemic heart disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e>), or <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> (<z:chebi fb="1" ids="17361">CMP</z:chebi>) presenting with pregnancy were enrolled </plain></SENT>
<SENT sid="2" pm="."><plain>Data for the <z:mpath ids='MPATH_458'>normal</z:mpath> population were derived from the literature </plain></SENT>
<SENT sid="3" pm="."><plain>Sixty hospitals in 28 countries enrolled 1321 pregnant women between 2007 and 2011 </plain></SENT>
<SENT sid="4" pm="."><plain>Median maternal age was 30 years (range 16-53) </plain></SENT>
<SENT sid="5" pm="."><plain>Most patients were in NYHA class I (72%) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0002564'>Congenital heart disease</z:hpo> (66%) was most prevalent, followed by <z:hpo ids='HP_0001654'>valvular heart disease</z:hpo> 25%, <z:chebi fb="1" ids="17361">CMP</z:chebi> 7%, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e> in 2% </plain></SENT>
<SENT sid="7" pm="."><plain>Maternal <z:hpo ids='HP_0011420'>death</z:hpo> occurred in 1%, compared with 0.007% in the <z:mpath ids='MPATH_458'>normal</z:mpath> population </plain></SENT>
<SENT sid="8" pm="."><plain>Highest maternal mortality was found in patients with <z:chebi fb="1" ids="17361">CMP</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>During pregnancy, 338 patients (26%) were hospitalized, 133 for <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Caesarean section was performed in 41% </plain></SENT>
<SENT sid="11" pm="."><plain>Foetal mortality occurred in 1.7% and neonatal mortality in 0.6%, both higher than in the <z:mpath ids='MPATH_458'>normal</z:mpath> population </plain></SENT>
<SENT sid="12" pm="."><plain>Median duration of pregnancy was 38 weeks (range 24-42) and median birth weight 3010 g (range 300-4850) </plain></SENT>
<SENT sid="13" pm="."><plain>In centres of developing countries, maternal and foetal mortality was higher than in centres of developed countries (3.9 vs. 0.6%, P &lt; 0.001 and 6.5 vs. 0.9% P &lt; 0.001)ConclusionThe vast majority of patients can go safely through pregnancy and delivery as long as adequate pre-pregnancy evaluation and specialized high-quality care during pregnancy and delivery are available </plain></SENT>
<SENT sid="14" pm="."><plain>Pregnancy outcomes were markedly worse in patients with <z:chebi fb="1" ids="17361">CMP</z:chebi> and in developing countries </plain></SENT>
</text></document>